Current treatment of systemic lupus erythematosus: a clinician's perspective
PB Katarzyna, S Wiktor, D Ewa - Rheumatology International, 2023 - Springer
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Its variable course
makes it difficult to standardize patient treatment. This article aims at a literature review on …
makes it difficult to standardize patient treatment. This article aims at a literature review on …
Assessment-Tools für den systemischen Lupus erythematodes
M Aringer, N Leuchten - Zeitschrift für Rheumatologie, 2023 - Springer
Ein systematisches Assessment ist entscheidend, um die heutigen Möglichkeiten eines
optimalen SLE (systemischer Lupus erythematodes)-Managements zu nützen. Ohne …
optimalen SLE (systemischer Lupus erythematodes)-Managements zu nützen. Ohne …
Egyptian recommendations for the management of systemic lupus erythematosus: a consensus, evidence-based, clinical practice guidelines for treat-to-target …
Y El Miedany, K Elhadidi, GA Mahmoud… - Egyptian Rheumatology …, 2023 - Springer
Background Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease
characterized by having varying clinical presentation, severity, unpredictable course as well …
characterized by having varying clinical presentation, severity, unpredictable course as well …
No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective …
M Ayano, A Hirata, S Tokunaga, H Furuhashi… - Rheumatology …, 2024 - Springer
This study aimed to clarify the efficacy and safety of treatment escalation by initiating
therapeutic agents in serologically active clinically quiescent (SACQ) patients with systemic …
therapeutic agents in serologically active clinically quiescent (SACQ) patients with systemic …
Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis
C De Mutiis, SE Wenderfer, B Basu, A Bagga… - Pediatric …, 2024 - Springer
Background Lupus nephritis (LN) is a very severe manifestation of lupus. There is no
consensus on which treatment goals should be achieved to protect kidney function in …
consensus on which treatment goals should be achieved to protect kidney function in …
Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study)
M Jaïs, P Roblot, F Maillot, M Hamidou… - Rheumatology …, 2024 - Springer
Data about the impact of Belimumab on corticosteroid sparing in real life are scarce. To
assess the corticosteroid-sparing effect among patients with systemic lupus erythematosus …
assess the corticosteroid-sparing effect among patients with systemic lupus erythematosus …
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3 …
C Aranow, CF Allaart, Z Amoura, IN Bruce… - Annals of the …, 2024 - ard.bmj.com
Objectives Disease activity control in patients with systemic lupus erythematosus (SLE) with
corticosteroid and immunosuppressant withdrawal is a treatment goal. We evaluated …
corticosteroid and immunosuppressant withdrawal is a treatment goal. We evaluated …
Lupusnephritis
J Mucke, M Schneider - Zeitschrift für Rheumatologie, 2023 - Springer
Die Lupusnephritis (LN) ist eine der häufigsten Organmanifestation des systemischen Lupus
erythematodes. Zum Screening eignet sich die Urinanalyse, bei der eine Proteinurie oder …
erythematodes. Zum Screening eignet sich die Urinanalyse, bei der eine Proteinurie oder …
Die 2023 EULAR-Empfehlungen zur Behandlung des systemischen Lupus erythematodes–Implikationen für die Versorgung in Deutschland
J Mucke, M Aringer - Zeitschrift für Rheumatologie, 2024 - Springer
Zusammenfassung Das Update 2023 der EULAR (European Alliance of Associations for
Rheumatology)-Empfehlungen für das Management des systemischen Lupus …
Rheumatology)-Empfehlungen für das Management des systemischen Lupus …
P339 Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease
E Theodoraki MD-MA-PhD c… - Journal of Crohn's …, 2022 - academic.oup.com
Background The detection of antinuclear antibodies (ANA) in serum of patients with
inflammatory bowel disease (IBD) has been associated with a worse response to anti-TNF …
inflammatory bowel disease (IBD) has been associated with a worse response to anti-TNF …